{"id":9,"date":"2023-12-18T22:47:36","date_gmt":"2023-12-18T22:47:36","guid":{"rendered":"https:\/\/abbctherapies.com\/?page_id=9"},"modified":"2024-04-02T13:51:57","modified_gmt":"2024-04-02T13:51:57","slug":"homepage","status":"publish","type":"page","link":"https:\/\/abbctherapies.com\/","title":{"rendered":"Homepage"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull has-global-padding is-layout-constrained wp-container-core-group-is-layout-2 wp-block-group-is-layout-constrained\" style=\"padding-top:var(--wp--preset--spacing--50);padding-right:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--50);padding-left:var(--wp--preset--spacing--50)\">\n<div class=\"wp-block-group is-layout-flow wp-container-core-group-is-layout-1 wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"365\" src=\"https:\/\/abbctherapies.com\/wp-content\/uploads\/2023\/12\/AbBC-logo-full-color-small-1024x365.png\" alt=\"AbBC logo\" class=\"wp-image-43\" srcset=\"https:\/\/abbctherapies.com\/wp-content\/uploads\/2023\/12\/AbBC-logo-full-color-small-1024x365.png 1024w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2023\/12\/AbBC-logo-full-color-small-300x107.png 300w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2023\/12\/AbBC-logo-full-color-small-768x274.png 768w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2023\/12\/AbBC-logo-full-color-small-1536x547.png 1536w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2023\/12\/AbBC-logo-full-color-small-2048x730.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<div style=\"height:1.25rem\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-text-align-center\" style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.708), 1.3rem);\"><strong style=\"color: #e0633b\">AbBC Therapies<\/strong> is a next generation ADC and immunotoxin company that utilizes a biological conjugation process to target and deliver Granzyme B to cells<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<figure class=\"wp-block-image aligncenter size-medium align-center\"><a href=\"\/wp-content\/uploads\/2024\/04\/AbBC-Investor-presentation-finalApril12024.pdf\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"168\" src=\"https:\/\/abbctherapies.com\/wp-content\/uploads\/2024\/04\/abbc-cover-investor-300x168.png\" alt=\"\" class=\"wp-image-71\" srcset=\"https:\/\/abbctherapies.com\/wp-content\/uploads\/2024\/04\/abbc-cover-investor-300x168.png 300w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2024\/04\/abbc-cover-investor-1024x572.png 1024w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2024\/04\/abbc-cover-investor-768x429.png 768w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2024\/04\/abbc-cover-investor-1536x858.png 1536w, https:\/\/abbctherapies.com\/wp-content\/uploads\/2024\/04\/abbc-cover-investor-2048x1145.png 2048w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/figure>\n\n\n\n<p class=\"has-text-align-center\"><a href=\"\/wp-content\/uploads\/2024\/04\/AbBC-Investor-presentation-finalApril12024.pdf\" data-type=\"attachment\" data-id=\"49\" target=\"_blank\" rel=\"noreferrer noopener\">View our Investor Presentation<\/a><\/p>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<p class=\"has-text-align-center\">To learn more, please contact:<br>Claire Thuning-Roberson, PhD, CEO; email: claireroberson@h2biologics.com, cell: 954-661-7555<br>Ian Estepan, Executive Chairman; email: iestepan@sarepta.com, cell: 617-460-9771<\/p>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AbBC Therapies is a next generation ADC and immunotoxin company that utilizes a biological conjugation process to target and deliver Granzyme B to cells View our Investor Presentation To learn more, please contact:Claire Thuning-Roberson, PhD, CEO; email: claireroberson@h2biologics.com, cell: 954-661-7555Ian Estepan, Executive Chairman; email: iestepan@sarepta.com, cell: 617-460-9771<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/pages\/9"}],"collection":[{"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/comments?post=9"}],"version-history":[{"count":26,"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/pages\/9\/revisions"}],"predecessor-version":[{"id":74,"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/pages\/9\/revisions\/74"}],"wp:attachment":[{"href":"https:\/\/abbctherapies.com\/wp-json\/wp\/v2\/media?parent=9"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}